WallStreetZenWallStreetZen

NASDAQ: HSIC
Henry Schein Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Henry Schein earnings were $395.0M for the trailing 12 months ending Mar 28, 2026, with 2.8% growth year over year. The latest HSIC earnings report on Mar 28, 2026 announced Q1 2026 earnings of $107.0M, up 5.9% from last quarter. For the last reported fiscal year 2025 ending Dec 27, 2025, HSIC reported annual earnings of $398.0M, with 2.1% growth. The next HSIC earnings date is Aug 4, 2026.

HSIC past earnings growth

How has HSIC's earnings growth performed historically?

Company
2.78%
Industry
35.51%
Market
89.73%
HSIC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
HSIC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
HSIC's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

HSIC earnings history

Current Revenue
$13.4B
Current Earnings
$395.0M
Current Profit Margin
3%
HSIC's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

HSIC Return on Equity

Current Company
11.9%
Current Industry
-105.1%
Current Market
13.5%
HSIC's Return on Equity (11.9%)... subscribe to Premium to read more.
High Return on Equity Performance

HSIC Return on Assets

Current Company
3.5%
Current Industry
4.3%
HSIC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when HSIC announces earnings.

HSIC Return on Capital Employed

Current Company
8.47%
Current Industry
26.8%
HSIC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HSIC vs Medical Distribution Stocks

TickerEBITDAEarningsY/Y EarningsEPS
HSIC$997.00M$395.00M+1.51%$3.33
AHG-$163.37M-$135.67MN/A-$0.48
ACH-$759.16M-$1.08BN/A-$14.08
FOCLN/A-$36.77MN/A-$0.98
COSM-$16.49M-$21.13MN/A-$0.64
View Top Medical Distribution Stocks

HSIC earnings dates

Next earnings date
Aug 4, 2026

Henry Schein Earnings Reports & History FAQ

What were Henry Schein's earnings last quarter?

Henry Schein (NASDAQ: HSIC) reported Q1 2026 earnings per share (EPS) of $0.93, up 4.49% year over year. Total HSIC earnings for the quarter were $107.00 million. In the same quarter last year, Henry Schein's earnings per share (EPS) was $0.89.

If you're new to stock investing, here's how to buy Henry Schein stock.

When does Henry Schein report earnings?

The next HSIC earnings date is Invalid Date. Add HSIC to your watchlist to be reminded of Henry Schein's next earnings date.

Is Henry Schein profitable or losing money?

As of the last Henry Schein earnings report, Henry Schein is currently profitable. Henry Schein's net profit (also called net income) for the twelve months ending Mar 28, 2026 was $395.00 million, a 2.95% decrease year over year.

What was HSIC's earnings growth in the past year?

As of Henry Schein's earnings date in Q2 2026, Henry Schein's earnings has grown 2.78% year over year. This is 32.74 percentage points lower than the US Medical Distribution industry earnings growth rate of 35.51%. HSIC earnings in the past year totalled $395.00 million.

What are Henry Schein's earnings expectations?

The current EPS estimate for Henry Schein's earnings report in Invalid Date is $1.23.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.